Myasthenia Gravis is an autoimmune neuromuscular junction disorder causing fluctuating, fatigable weakness. Accurate diagnosis integrates antibody testing, electrophysiology, thymic imaging, and targeted treatment strategies for ... Aug 31
Pediatric epilepsy requires early diagnosis, precision-matched anti-seizure medications, ketogenic dietary therapy, and continuous developmental monitoring. A multidisciplinary approach can improve seizure control while ... Aug 29
The global healthcare delivery landscape is undergoing a major structural realignment. For decades, traditional acute care hospitals functioned as the primary, all-encompassing entry point ... Jul 27
Air pollution causes widespread respiratory, cardiovascular, and neurological harm in India. Vulnerable groups include children, pregnant women, and the elderly. Prevention requires both systemic policy ... Jul 25
Recognising the seriousness of respiratory disease is the beginning of meaningful change. India cannot afford to normalise breathlessness as a consequence of urban living.... Dec 04
Asthma typically begins in childhood or early adulthood, although adult-onset asthma does exist.... Jun 26
Seek medical attention if the symptoms worsen, if the fever does not break, or if there is a production of yellow or green sputum, which ... Jan 07
The telltale signs of asthma and COPD somewhat overlap. Thus, it creates confusion. Get some deeper knowledge that will help you to distinguish between these. ... Mar 11
... Nov 03
Dr. Rohan Naick, Consultant Pulmonologist, SPARSH Hospital, Bangalore says that there is unnecessary stigma attached to inhalers but it is the best way to go ... Jun 21
New drug for eosinophilic asthma on the way... Jan 16
COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
AstraZeneca and Amgen today announced positive results from the new medicine tezepelumab in patients with severe, uncontrolled asthma.... Nov 10
PONENTE Phase IIIb open-label trial showed Fasenra eliminated the use of maintenance oral corticosteroids in OCS-dependent asthma patients with a broad range of ... Oct 29
Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD... Oct 19
A pivotal Phase 3 trial of Dupixent met its primary and all key secondary endpoints in children aged 6 to 11 years with uncontrolled moderate-... Oct 13
India’s first pressurized Metered Dose Inhaler for patients suffering from Chronic Obstructive Pulmonary Disease in India... Oct 08
... Sep 08
Novartis gets European Commission approval For Enerzair Breezhaler asthma treatment ... Jul 09
RMS is characterized by clearly defined attacks of worsening neurologic function. These attacks — often called relapses, flare-ups or exacerbations — are followed by partial or ... Sep 12
-Advertisements-
.jpeg)
Saturday, September 19, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)